Westlake Chemical Partners LP (NYSE:WLKP – Get Free Report) shares reached a new 52-week high during trading on Monday after the company announced better than expected quarterly earnings. The company traded as high as $25.04 and last traded at $24.73, with a volume of 12644 shares changing hands. The stock had previously closed at $24.22.
The basic materials company reported $0.43 EPS for the quarter, topping the consensus estimate of $0.36 by $0.07. Westlake Chemical Partners had a net margin of 5.40% and a return on equity of 7.31%.
Westlake Chemical Partners Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 25th. Stockholders of record on Friday, February 7th will be given a dividend of $0.4714 per share. This represents a $1.89 annualized dividend and a dividend yield of 7.67%. The ex-dividend date of this dividend is Friday, February 7th. This is an increase from Westlake Chemical Partners’s previous quarterly dividend of $0.47. Westlake Chemical Partners’s payout ratio is currently 107.43%.
Institutional Trading of Westlake Chemical Partners
Westlake Chemical Partners Stock Up 1.5 %
The firm has a market cap of $866.00 million, a PE ratio of 14.04 and a beta of 1.09. The company has a debt-to-equity ratio of 0.48, a quick ratio of 4.46 and a current ratio of 4.53. The firm’s 50-day moving average price is $23.73 and its two-hundred day moving average price is $23.08.
Westlake Chemical Partners Company Profile
Westlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. The company’s ethylene production facilities primarily convert ethane into ethylene. It also sells ethylene co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on either a spot or contract basis.
Featured Stories
- Five stocks we like better than Westlake Chemical Partners
- Profitably Trade Stocks at 52-Week Highs
- 3 Beaten Down Healthcare Stocks Recovering in 2025
- Why Are Stock Sectors Important to Successful Investing?
- These 3 Unusual ETFs Have Dominated the S&P 500’s Performance YTD
- What does consumer price index measure?
- UnitedHealth’s RSI Suggests It Is Extremely Oversold
Receive News & Ratings for Westlake Chemical Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Westlake Chemical Partners and related companies with MarketBeat.com's FREE daily email newsletter.